Juvenile Idiopathic Arthritis Workup

  • Author: David D Sherry, MD; Chief Editor: Lawrence K Jung, MD   more...
 
Updated: Dec 8, 2011
 

Approach Considerations

The diagnosis of juvenile idiopathic arthritis (JIA) is based on the history and physical examination findings. No laboratory studies are diagnostic for JIA, and indeed, all laboratory study findings may be normal in children with this disorder. However, laboratory studies help to exclude other underlying disorders, classify the type of arthritis, and evaluate for extra-articular manifestations of JIA. Imaging of affected joints is usually indicated.

When physical findings do not document definite arthritis, further evaluation is warranted. The choice of studies varies on the basis of the specific circumstances.

Go to Imaging in Juvenile Rheumatoid Arthritis for complete information on this topic.

Next

Inflammatory Markers

The erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) level is usually elevated in children with systemic-onset JIA (with a disproportionate increase in the CRP) and may be elevated in those with polyarticular disease; however, it is often within the reference range in those with oligoarticular disease. When elevated, inflammatory markers can be used to monitor disease activity.

Other markers of inflammation include thrombocytosis, leukocytosis, complement, and, in a reverse fashion, albumin and hemoglobin

Previous
Next

Complete Blood Count and Metabolic Panel

Lymphopenia is not uncommon because of emigration of activated lymphocytes out of the circulation into synovium. However, neutropenia is uncommon and, particularly with lymphocytosis or thrombocytopenia, raises the possibility of acute lymphocytic leukemia.

A complete blood count, liver function tests (to exclude the possibility of viral or autoimmune hepatitis), and assessment of renal function with serum creatinine levels should be done before starting treatment with nonsteroidal anti-inflammatory drugs (NSAIDs), methotrexate (MTX), or tumor necrosis factor–alpha inhibitors.

Previous
Next

Antinuclear Antibody Testing

As many as 70% of children with oligoarticular JIA have positive ANA assays. However, a positive ANA should also raise suspicion of systemic lupus erythematosus (SLE). Overlap between the manifestations of the two disorders may lead to initial misdiagnosis of SLE as JIA.

A positive ANA is a marker for increased risk of anterior uveitis. Children younger than 6 years at arthritis onset with a positive ANA finding are in the highest risk category for development of uveitis and need slit lamp screening every 3-4 months. Titers do not correlate with disease activity.

Previous
Next

Additional Laboratory Tests

In systemic-onset JIA, total protein and albumin levels are often decreased during active disease, and fibrinogen, ferritin and D-dimer levels are often elevated. Laboratory results that can help to rule out JIA include angiotensin-converting enzyme (ACE) elevation, which may be indicative of sarcoidosis, and antistreptolysin 0 (AS0) and anti-DNAse B elevations, which may indicate acute rheumatic fever or poststreptococcal arthritis.

Perform a urinalysis to exclude the possibility of infection (as a trigger for JIA or transient postinfectious arthritis). Proteinuria (>0.5 g/d or 3+ positive on dipstick testing) or cellular casts is consistent with renal involvement in SLE.

In patients with systemic-onset JIA, the following test results are indicative of the development of macrophage-activating syndrome (MAS):

  • Falling ESR
  • Normalization or decrease in white blood cell (WBC) count
  • Low platelets
  • Elevated liver enzymes
  • Increased ferritin
  • Increased triglycerides
  • Low fibrinogen
  • Erratic fevers
  • Hemorrhages (disseminated intravascular coagulation–like pattern)
Previous
Next

Radiography

When only a single joint is affected, radiography is important to exclude other diseases, such as osteomyelitis. Basic radiographic changes in JIA (see the images below) include the following:

  • Soft tissue swelling
  • Osteopenia and/or osteoporosis
  • Joint-space narrowing
  • Bony erosions
  • Intra-articular bony ankylosis
  • Periosteitis
  • Growth disturbances
  • Epiphyseal compression fracture
  • Joint subluxation
  • Synovial cystsAnkylosis in the cervical spine at several levels Ankylosis in the cervical spine at several levels due to long-standing juvenile rheumatoid arthritis (also known as juvenile idiopathic arthritis). Widespread osteopenia, carpal crowding (due to carWidespread osteopenia, carpal crowding (due to cartilage loss), and several erosions affecting the carpal bones and metacarpal heads in particular in a child with advanced juvenile rheumatoid arthritis (also known as juvenile idiopathic arthritis).

The main limitation of conventional radiography is that it does not allow direct examination of the articular cartilage, synovium, and other important noncalcified structures in a joint.

Go to Imaging in Juvenile Rheumatoid Arthritis for complete information on this topic.

Previous
Next

Computed Tomography and Magnetic Resonance Imaging

CT scanning is the best method for analyzing bony abnormalities, but it has been largely superseded by MRI in the overall assessment of JIA. The major disadvantage of CT scanning is that it involves a substantial radiation dose. Perform CT scanning of the long bones when considering osteoid osteoma is suspected.

MRI is helpful when considering trauma in the differential diagnosis. In addition, imaging of the TMJ, sacroiliac joint, cervical spine, midfoot, hip, or shoulder is useful in diagnosing inflammatory arthritis. (See the image below.)

(A) T2-weighted MRI shows high signal in both hips(A) T2-weighted MRI shows high signal in both hips, which may be due to hip effusions or synovitis. High signal intensity in the left femoral head indicates avascular necrosis. (B) Coronal fat-saturated gadolinium-enhanced T1-weighted MRI shows bilateral enhancement in the hips. This indicated bilateral active synovitis, which is most pronounced on the right. Because the image was obtained with fat saturation, the hyperintensity in both hips is pathologic, reflecting an inflamed pannus.

MRI provides the most sensitive radiologic indicator of disease activity. The modality can depict synovial hypertrophy, define soft tissue swelling, and demonstrate excellent detail of the status of articular cartilage and overall joint integrity.[16, 17, 18, 19, 1, 2, 3, 20, 21]

To improve visualization of synovial hypertrophy and improve detection of cartilaginous erosions when an inflammatory arthritis is suspected, contrast-enhanced sequences should be performed.

Synovitis and a joint effusion may have similar hyperintensity on T2-weighted (T2W) and short-tau inversion recovery (STIR) images. Therefore, gadolinium-enhanced T1-weighted (T1W) MRIs are necessary to accurately define active synovitis.

Note that gadolinium-based contrast agents (gadopentetate dimeglumine [Magnevist], gadobenate dimeglumine [MultiHance], gadodiamide [Omniscan], gadoversetamide [OptiMARK], gadoteridol [ProHance]) have been linked to the development of nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). For more information, see the Medscape Reference topic Nephrogenic Systemic Fibrosis.

Go to Imaging in Juvenile Rheumatoid Arthritis for complete information on this topic.

Previous
Next

Ultrasonography

On ultrasonograms, inflamed synovium can appear as an area of mixed echogenicity lining the articular cartilage; the vascularity of the synovium can be assessed with Doppler flow studies. Serial measurements of synovial thickness and effusion volumes have been used to monitor disease progression.[22] It can be helpful to evaluate joints that are difficult to palpate, such as the hip and shoulder.

Some researchers claim that ultrasonography is more sensitive than plain radiography in the detection of cartilage erosions and effusions. Ultrasound has the advantages of no exposure to ionizing radiation; it can be done in the clinic is an awake, moving child; and it can help guide injections.

Go to Imaging in Juvenile Rheumatoid Arthritis for complete information on this topic.

Previous
Next

Nuclear Imaging

Bone scanning, which can be used in the assessment of JIA, is characterized as follows:

  • This modality can be used when physical findings do not document definite arthritis.
  • It can also be used to identify a potential focus of osteomyelitis, osteoid osteoma or other abnormality.
  • Bone scanning is characterized by high sensitivity and low specificity
  • It may be combined with single-photon emission CT (SPECT) scanning to increase sensitivity in the 1 or more foci of abnormal isotopic accumulation.
  • Bone scintigraphy is primarily used in the determination of the distribution of JIA, but the substantial radiation dose from this modality is a major disadvantage

Go to Imaging in Juvenile Rheumatoid Arthritis for complete information on this topic.

Previous
Next

Echocardiography

In a child who has nonspecific rash, adenopathy, and possible mucocutaneous changes, perform echocardiography to exclude coronary arterial dilation resulting from Kawasaki disease. In an individual who has findings suggestive of SLE (eg, nephritis, pleuritic chest pain, thrombocytopenia), perform echocardiography to exclude valvular disease, although mild dilation may be seen in some patients with systemic-onset JIA.

Previous
Next

Other Studies and Procedures

Perform dual energy radiographic absorptiometry (DRA) scanning to document osteopenia in children with JIA, especially in children requiring long-term steroids (systemic JIA) or with prolonged widespread arthritis.

Perform arthrocentesis to exclude septic arthritis in a child with monoarticular swelling. Synovial biopsy may be helpful to exclude other diagnoses, particularly when the knee is affected (eg, villonodular synovitis, granulomatous arthritis, foreign body synovitis). Synovial biopsy may reveal synovial infiltration with plasma cells, mature B lymphocytes, and T lymphocytes, with areas of synovial thickening and fibrosis.

Pericardiocentesis is used in an intensive care unit (ICU) setting to treat severe pericarditis.

Previous
 
 
Contributor Information and Disclosures
Author

David D Sherry, MD  Director, Clinical Rheumatology, Attending Physician, Pain Management, The Children's Hospital of Philadelphia; Professor of Pediatrics, University of Pennsylvania School of Medicine

David D Sherry, MD is a member of the following medical societies: American College of Rheumatology and American Pain Society

Disclosure: Nothing to disclose.

Coauthor(s)

C Egla Rabinovich, MD, MPH  Associate Professor and Co-Division Chief, Department of Pediatrics, Division of Pediatric Rheumatology, Duke University Medical Center

C Egla Rabinovich, MD, MPH is a member of the following medical societies: American College of Rheumatology

Disclosure: Abbott Grant/research funds clincal trial; Pfizer Grant/research funds clinical trial; Centacor Grant/research funds clinical trial

Murali Poduval, MBBS, MS, DNB  Additional Professor in Orthopedic Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India

Murali Poduval, MBBS, MS, DNB is a member of the following medical societies: Association of Medical Consultants of Mumbai, Bombay Orthopedic Society, Indian Orthopedic Association, and Indian Society of Hip and Knee Surgeons

Disclosure: Nothing to disclose.

Atul R S Bhaskar, MBBS, MCh, MS, FRCS, DNB(Orth)  Assistant Professor, Department of Orthopedics, K J Somaiya Medical College Hospital; Consulting Staff, Department of Orthopedic Surgery, BSES MG Hospital, India

Atul R S Bhaskar, MBBS, MCh, MS, FRCS, DNB(Orth) is a member of the following medical societies: Royal College of Physicians and Surgeons of Glasgow

Disclosure: Nothing to disclose.

Specialty Editor Board

Barry L Myones, MD  Associate Professor, Departments of Pediatrics and Immunology, Pediatric Rheumatology Section, Baylor College of Medicine; Director of Research, Pediatric Rheumatology Center, Texas Children's Hospital

Barry L Myones, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American College of Rheumatology, American Heart Association, American Society for Microbiology, Clinical Immunology Society, and Texas Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Mininder S Kocher, MD, MPH  Associate Professor of Orthopedic Surgery, Harvard Medical School/Harvard School of Public Health; Associate Director, Division of Sports Medicine, Department of Orthopedic Surgery, Children's Hospital Boston

Mininder S Kocher, MD, MPH is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association for the History of Medicine, American College of Sports Medicine, American Orthopaedic Society for Sports Medicine, Massachusetts Medical Society, and Pediatric Orthopaedic Society of North America

Disclosure: Smith & Nephew Endoscopy Consulting fee Consulting; EBI Biomet Consulting fee Consulting; OrthoPediatrics Consulting fee Consulting; Pivot Medical Stock Consulting; pediped Consulting fee Consulting; WB Saunders Royalty None; Fixes-4-Kids Consulting

Dennis P Grogan, MD  Clinical Professor, Department of Orthopedic Surgery, University of South Florida College of Medicine; Chief of Staff, Department of Orthopedic Surgery, Shriners Hospital for Children of Tampa

Dennis P Grogan, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Medical Association, American Orthopaedic Association, American Orthopaedic Foot and Ankle Society, Eastern Orthopaedic Association, Irish American Orthopaedic Society, Pediatric Orthopaedic Society of North America, and Scoliosis Research Society

Disclosure: Nothing to disclose.

Chief Editor

Lawrence K Jung, MD  Chief, Division of Pediatric Rheumatology, Children's National Medical Center

Lawrence K Jung, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Rheumatology, Clinical Immunology Society, and New York Academy of Sciences

Disclosure: Nothing to disclose.

References
  1. Lamer S, Sebag GH. MRI and ultrasound in children with juvenile chronic arthritis. Eur J Radiol. Feb 2000;33(2):85-93. [Medline].

  2. Argyropoulou MI, Margariti PN, Karali A, Astrakas L, Alfandaki S, Kosta P, et al. Temporomandibular joint involvement in juvenile idiopathic arthritis: clinical predictors of magnetic resonance imaging signs. Eur Radiol. Mar 2009;19(3):693-700. [Medline].

  3. Lee EY, Sundel RP, Kim S, Zurakowski D, Kleinman PK. MRI findings of juvenile psoriatic arthritis. Skeletal Radiol. Nov 2008;37(11):987-96. [Medline].

  4. Barton A, Worthington J. Genetic susceptibility to rheumatoid arthritis: an emerging picture. Arthritis Rheum. Oct 15 2009;61(10):1441-6. [Medline].

  5. Hinks A, Ke X, Barton A, Eyre S, Bowes J, Worthington J, et al. Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum. Jan 2009;60(1):251-7. [Medline]. [Full Text].

  6. Yanagimachi M, Miyamae T, Naruto T, Hara T, Kikuchi M, Hara R, et al. Association of HLA-A(*)02:06 and HLA-DRB1(*)04:05 with clinical subtypes of juvenile idiopathic arthritis. J Hum Genet. Mar 2011;56(3):196-9. [Medline].

  7. Scola MP, Imagawa T, Boivin GP, Giannini EH, Glass DN, Hirsch R, et al. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. Arthritis Rheum. Apr 2001;44(4):794-801. [Medline].

  8. Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J, et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum. Dec 2008;58(12):3924-31. [Medline]. [Full Text].

  9. Ayaz NA, Ozen S, Bilginer Y, Ergüven M, Taskiran E, Yilmaz E, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford). Jan 2009;48(1):23-5. [Medline].

  10. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. Jan 2008;58(1):15-25. [Medline]. [Full Text].

  11. Orphanet. Enthesitis-related arthritis. Available at http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=85438.

  12. Sullivan DB, Cassidy JT, Petty RE. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum. May-Jun 1975;18(3):251-5. [Medline].

  13. Simard JF, Neovius M, Hagelberg S, Askling J. Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study. Arthritis Rheum. Dec 2010;62(12):3776-82. [Medline].

  14. Cassidy J, Kivlin J, Lindsley C, Nocton J. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. May 2006;117(5):1843-5. [Medline].

  15. Lovell DJ. Juvenile Idiopathic Arthritis: Clinical Features. In: Kippel JH, Stone JH, Crofford LJ, White PH, Eds. Primer on the Rheumatic Diseases. 13th Ed. Springer Science, New York: 2008.

  16. Johnson K, Gardner-Medwin J. Childhood arthritis: classification and radiology. Clin Radiol. Jan 2002;57(1):47-58. [Medline].

  17. McHugh K, Gupta R, Murray K. Imaging in juvenile chronic arthritis. Imaging. 1999;11:91-7.

  18. Pedersen TK, Küseler A, Gelineck J, Herlin T. A prospective study of magnetic resonance and radiographic imaging in relation to symptoms and clinical findings of the temporomandibular joint in children with juvenile idiopathic arthritis. J Rheumatol. Aug 2008;35(8):1668-75. [Medline].

  19. Gylys-Morin VM. MR imaging of pediatric musculoskeletal inflammatory and infectious disorders. Magn Reson Imaging Clin N Am. Aug 1998;6(3):537-59. [Medline].

  20. Workie DW, Graham TB, Laor T, Rajagopal A, O'Brien KJ, Bommer WA, et al. Quantitative MR characterization of disease activity in the knee in children with juvenile idiopathic arthritis: a longitudinal pilot study. Pediatr Radiol. Jun 2007;37(6):535-43. [Medline].

  21. Nistala K, Babar J, Johnson K, Campbell-Stokes P, Foster K, Ryder C, et al. Clinical assessment and core outcome variables are poor predictors of hip arthritis diagnosed by MRI in juvenile idiopathic arthritis. Rheumatology (Oxford). Apr 2007;46(4):699-702. [Medline].

  22. Shanmugavel C, Sodhi KS, Sandhu MS, Sidhu R, Singh S, Katariya S, et al. Role of power Doppler sonography in evaluation of therapeutic response of the knee in juvenile rheumatoid arthritis. Rheumatol Int. Apr 2008;28(6):573-8. [Medline].

  23. American College of Rheumatology, Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. Feb 2002;46(2):328-46. [Medline].

  24. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, Dewitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). Apr 2011;63(4):465-82. [Medline].

  25. Efficacy and safety of tocilizumab in patients with systemic Juvenile Idiopathic Arthritis (sJIA): 12-week data from the phase 3 TENDER trial. Abstract presented on June 18, 2010. European League Against Rheumatism (EULAR). [Full Text].

  26. Otten MH, Prince FH, Armbrust W, et al. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA. Dec 7 2011;306(21):2340-7. [Medline].

  27. American College of Rheumatology, Section on Pediatric Rheumatology. Position statement: guidelines for referral of children and adolescents to pediatric rheumatologists. Available at http://www.rheumatology.org/sections/pediatric/ped_referral.pdf. Accessed November 11, 1997.

  28. Chmell MJ, Scott RD, Thomas WH, Sledge CB. Total hip arthroplasty with cement for juvenile rheumatoid arthritis. Results at a minimum of ten years in patients less than thirty years old. J Bone Joint Surg Am. Jan 1997;79(1):44-52. [Medline].

  29. Dabov G, Perez EA. Miscellaneous nontraumatic disorders: rheumatoid arthritis. In: Canale ST, ed. Campbell's Operative Orthopaedics. 10th ed. St Louis, Mo: Mosby; 2003.

  30. Delf Witt J. Surgical intervention and sports medicine: surgery in children. In: Isenberg D, Maddison P, Woo P, et al, eds. Oxford Textbook of Rheumatology. New York, NY: Oxford University Press; 2004:1220-8.

  31. Goodman SB, Oh KJ, Imrie S, Hwang K, Shegog M. Revision total hip arthroplasty in juvenile chronic arthritis: 17 revisions in 11 patients followed for 4-12 years. Acta Orthop. Apr 2006;77(2):242-50. [Medline].

  32. Hanson V, Kornreich HK, Bernstein B, et al. subtypes of juvenile rheumatoid arthritis (correlations of age at onset, sex, and serologic factors). Arthritis Rheum. (Suppl): 20;48(1):184.

  33. Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics. Jan 2002;109(1):109-15. [Medline].

  34. [Best Evidence] Kapetanovic MC, Lindqvist E, Saxne T, Eberhardt K. Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement. Ann Rheum Dis. Oct 2008;67(10):1412-6. [Medline].

  35. Lehtimäki MY, Lehto MU, Kautiainen H, Savolainen HA, Hämäläinen MM. Survivorship of the Charnley total hip arthroplasty in juvenile chronic arthritis. A follow-up of 186 cases for 22 years. J Bone Joint Surg Br. Sep 1997;79(5):792-5. [Medline].

  36. Lybäck CO, Lehto MU, Hämäläinen MM, Belt EA. Patellar resurfacing reduces pain after TKA for juvenile rheumatoid arthritis. Clin Orthop Relat Res. Jun 2004;152-6. [Medline].

  37. McCullough CJ. Surgical management of the hip in juvenile chronic arthritis. Br J Rheumatol. Feb 1994;33(2):178-83. [Medline].

  38. Mulhall KJ, Saleh KJ, Thompson CA, Severson EP, Palmer DH. Results of bilateral combined hip and knee arthroplasty in very young patients with juvenile rheumatoid arthritis. Arch Orthop Trauma Surg. Mar 2008;128(3):249-54. [Medline].

  39. Odent T, Journeau P, Prieur AM, Touzet P, Pouliquen JC, Glorion C. Cementless hip arthroplasty in juvenile idiopathic arthritis. J Pediatr Orthop. Jul-Aug 2005;25(4):465-70. [Medline].

  40. Oh KJ, Imrie S, Hwang K, Ramachandran R, Shegog M, Goodman SB. Total hip arthroplasty using the miniature Anatomic Medullary Locking stem. Clin Orthop Relat Res. Jun 2006;447:85-91. [Medline].

  41. Palmer DH, Mulhall KJ, Thompson CA, Severson EP, Santos ER, Saleh KJ. Total knee arthroplasty in juvenile rheumatoid arthritis. J Bone Joint Surg Am. Jul 2005;87(7):1510-4. [Medline].

  42. Thomas A, Rojer D, Imrie S, Goodman SB. Cemented total knee arthroplasty in patients with juvenile rheumatoid arthritis. Clin Orthop Relat Res. Apr 2005;140-6. [Medline].

  43. Williams WW, McCullough CJ. Results of cemented total hip replacement in juvenile chronic arthritis. A radiological review. J Bone Joint Surg Br. Nov 1993;75(6):872-4. [Medline].

  44. Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty in young rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years. Acta Orthop. Apr 2007;78(2):206-10. [Medline].

  45. Yun AG, Martin S, Zurakowski D, Scott R. Bipolar hemiarthroplasty in juvenile rheumatoid arthritis: long-term survivorship and outcomes. J Arthroplasty. Dec 2002;17(8):978-86. [Medline].

Previous
Next
 
Patient with active polyarticular arthritis. Note swelling (effusions) of all proximal interphalangeal (PIP) joints in addition to boney overgrowth. Also note lack of distal interphalangeal joint (DIP) involvement. The patient has interosseus muscle wasting (observed on the dorsum of the hands), and subluxation and ulnar deviation of the wrists are present. Image courtesy of Barry L. Myones, MD.
Wrist radiographs of the patient with active polyarticular arthritis shown in Media file 2. Note severe loss of cartilage in the intercarpal spaces and the radiocarpal space of the right wrist. A large erosion is present in the articular surface of the ulnar epiphysis. The view of the left wrist shows boney ankylosis involving the lateral 4 carpal bones with sparing of the pisiform. Erosions are present in the distal radius and ulna. Almost a loss of cartilage has occurred between the radius and ulna and the carpus. Narrowing of the carpal/metacarpal joints is present. Image courtesy of Barry L. Myones, MD.
Close-up of the proximal interphalangeal (PIP) effusions in the patient with active polyarthritis shown in Media files 2 and 3. Synovial thickening and effusion, as well as boney overgrowth, are present at the PIP joints bilaterally. Image courtesy of Barry L. Myones, MD.
Patient with inactive polyarticular arthritis. Long-term sequelae of polyarticular disease includes joint subluxation (note both wrists and thumbs), joint contractures (at proximal interphalangeal joints [PIPs] and distal interphalangeal joints [DIPs]), boney overgrowth (at all PIPs), and finger deformities (eg, swan-neck or boutonniere deformities). Image courtesy of Barry L. Myones, MD.
Hand and wrist radiographs of the patient with inactive polyarticular arthritis shown in Media file 5. Long-term sequelae of polyarticular disease includes periarticular osteopenia, generalized increase in the size of epiphyses, accelerated bone age, narrowed joint spaces (especially at the fourth and fifth proximal interphalangeal joints [PIPs] bilaterally), boutonniere deformities (at left third and fourth interphalangeal joints), and medial subluxation of the first metacarpophalangeal joints (MCPs) bilaterally. Flattening and erosion of the radial carpal articular surface is present in both wrists. Mild narrowing of the joint spaces exists at the carpometacarpal joints and intercarpal rows bilaterally, with sclerotic change of the intercarpal row (right > left). The trapezium and trapezoid may be fused bilaterally. Image courtesy of Barry L. Myones, MD.
Sequelae of chronic anterior uveitis. Note the posterior synechiae (weblike attachments of the pupillary margin to the anterior lens capsule) of the right eye secondary to chronic anterior uveitis. This patient has a positive antinuclear antibodies (ANAs) and initially had a pauciarticular course of her arthritis. She now has polyarticular involvement but no active uveitis. Image courtesy of Carlos A. Gonzales, MD.
One set of suggested algorithms for the treatment of patients with juvenile arthritis. This should not be considered dogmatic because treatment is not standardized and remains empiric and, at times, controversial.
Systemic juvenile idiopathic arthritis (JIA) rash.
Child with pericardial effusion due to systemic onset juvenile idiopathic arthritis (JIA).
Flexion and extension views of C-spine in child with poorly controlled polyarticular juvenile idiopathic arthritis (JIA).
Temporal-mandibular joint (TMJ) MRI postgadolinium infusion. Abnormal increased uptake indicative of synovitis in child with polyarticular juvenile idiopathic arthritis (JIA).
Eighteen-month-old girl with arthritis in her right knee. Note the flexion contracture of that knee.
Ankylosis in the cervical spine at several levels due to long-standing juvenile rheumatoid arthritis (also known as juvenile idiopathic arthritis).
Widespread osteopenia, carpal crowding (due to cartilage loss), and several erosions affecting the carpal bones and metacarpal heads in particular in a child with advanced juvenile rheumatoid arthritis (also known as juvenile idiopathic arthritis).
(A) T2-weighted MRI shows high signal in both hips, which may be due to hip effusions or synovitis. High signal intensity in the left femoral head indicates avascular necrosis. (B) Coronal fat-saturated gadolinium-enhanced T1-weighted MRI shows bilateral enhancement in the hips. This indicated bilateral active synovitis, which is most pronounced on the right. Because the image was obtained with fat saturation, the hyperintensity in both hips is pathologic, reflecting an inflamed pannus.
Table. Comparison of Classification Criteria for Chronic Childhood Arthritis
ClassificationACR(1977)ILAR (1997)
NomenclatureJuvenile rheumatoid arthritisJuvenile idiopathic arthritis
Minimum duration≥6 wk≥6 wk
Age at onset< 16 y< 16 y
≤ 4 joints in first 6 mo after presentationPauciarticular juvenile rheumatoid arthritisOligoarticular juvenile idiopathic arthritis:



(A) Persistent < 4 joints for course of disease;



(B) Extended >4 joints after 6 mo



>4 joints in first 6 mo after presentationPolyarticular juvenile rheumatoid arthritisPolyarticular juvenile idiopathic arthritis-rheumatoid factor negative



Polyarticular juvenile arthritis-rheumatoid factor positive



Fever, rash, arthritisSystemic juvenile rheumatoid arthritisSystemic juvenile idiopathic arthritis
Other categories includedExclusion of other formsPsoriatic juvenile idiopathic arthritis



Enthesitis-related arthritis



Undifferentiated:



(A) Fits no other category;



(B) Fits more than 1 category



Inclusion of psoriatic arthritis, inflammatory bowel disease, juvenile ankylosing spondylitisNoYes
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.